|
US7745491B2
(en)
|
2004-08-12 |
2010-06-29 |
Prosidion Limited |
Substituted phenylacetamides and their use as glucokinase activators
|
|
BRPI0618062A2
(pt)
*
|
2005-11-03 |
2011-08-16 |
Prosidion Ltd |
composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, processo para a preparação de um composto
|
|
EP2261216A3
(en)
*
|
2006-07-24 |
2011-12-14 |
F. Hoffmann-La Roche AG |
Pyrazoles as glucokinase activators
|
|
AU2007283113A1
(en)
|
2006-08-08 |
2008-02-14 |
Sanofi-Aventis |
Arylaminoaryl-alkyl-substituted imidazolidine-2,4-diones, processes for preparing them, medicaments comprising these compounds, and their use
|
|
TW200831081A
(en)
*
|
2006-12-25 |
2008-08-01 |
Kyorin Seiyaku Kk |
Glucokinase activator
|
|
EP2116533B1
(en)
*
|
2007-03-07 |
2013-07-10 |
Kyorin Pharmaceutical Co., Ltd. |
Glucokinase activator
|
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
PT2195312E
(pt)
*
|
2007-10-09 |
2013-02-20 |
Merck Patent Gmbh |
Derivados de piridina úteis como ativadores de glucocinase
|
|
AR070107A1
(es)
*
|
2008-01-15 |
2010-03-17 |
Lilly Co Eli |
R-2-(4-ciclopropansulfonil-fenil)-n-pirazin-2-il-3-(tetrahidropiran-4-il)-propionamida en forma cristalina, composicion farmaceutica que la comprende y su uso para la manufactura de un medicamento util para la prevencion o tratamiento de hiperglicemia
|
|
US8329707B2
(en)
|
2008-01-18 |
2012-12-11 |
Astellas Pharma Inc. |
Substituted pyrazine compounds
|
|
US7741327B2
(en)
|
2008-04-16 |
2010-06-22 |
Hoffmann-La Roche Inc. |
Pyrrolidinone glucokinase activators
|
|
US8258134B2
(en)
|
2008-04-16 |
2012-09-04 |
Hoffmann-La Roche Inc. |
Pyridazinone glucokinase activators
|
|
HUE025224T2
(en)
|
2008-04-28 |
2016-02-29 |
Kyorin Seiyaku Kk |
Ciklopentilakrilsav amide derivatives
|
|
US8563730B2
(en)
*
|
2008-05-16 |
2013-10-22 |
Takeda San Diego, Inc. |
Pyrazole and fused pyrazole glucokinase activators
|
|
UY31968A
(es)
|
2008-07-09 |
2010-01-29 |
Sanofi Aventis |
Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
UA104742C2
(uk)
|
2008-12-19 |
2014-03-11 |
Эли Лилли Энд Компани |
Похідні арилциклопропілацетаміду, застосовні як активатори глюкокінази
|
|
BR112012003973A2
(pt)
|
2009-08-26 |
2015-09-08 |
Sanofi Sa |
hidratos de fluoroglicosídeo heteroaromático cristalinos, produtos farmacêuticos compreendendo estes compostos e seu uso
|
|
US8222416B2
(en)
|
2009-12-14 |
2012-07-17 |
Hoffmann-La Roche Inc. |
Azaindole glucokinase activators
|
|
CN102146078A
(zh)
*
|
2010-02-09 |
2011-08-10 |
中国科学院上海药物研究所 |
一类取代的丙酰胺类化合物、其制备方法及用途
|
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8933024B2
(en)
|
2010-06-18 |
2015-01-13 |
Sanofi |
Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2683705B1
(de)
|
2011-03-08 |
2015-04-22 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120052A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8710050B2
(en)
|
2011-03-08 |
2014-04-29 |
Sanofi |
Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
WO2012120053A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013045413A1
(en)
|
2011-09-27 |
2013-04-04 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|